Critical Comparison: Jin Medical International (NASDAQ:ZJYL) & Smith & Nephew (NYSE:SNN)

Smith & Nephew (NYSE:SNN) and Jin Medical International (NASDAQ:ZJYL) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, profitability, valuation, analyst recommendations, dividends and institutional ownership.

Valuation and Earnings

This table compares Smith & Nephew and Jin Medical International”s top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Smith & Nephew	$5.81 billion	2.16	$263.00 million	$2.16	13.24
Jin Medical International	$23.50 million	5.08	$3.68 million	N/A	N/A

Smith & Nephew has higher revenue and earnings than Jin Medical International.

Risk & Volatility

Smith & Nephew has a beta of 0.71, meaning that its stock price is 29% less volatile than the S&P 500. Comparatively, Jin Medical International has a beta of 12.24, meaning that its stock price is 1,124% more volatile than the S&P 500.

Insider & Institutional Ownership

25.6% of Smith & Nephew shares are held by institutional investors. 1.0% of Smith & Nephew shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Smith & Nephew and Jin Medical International’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Smith & Nephew	N/A	N/A	N/A
Jin Medical International	N/A	N/A	N/A

Analyst Ratings

This is a summary of current recommendations for Smith & Nephew and Jin Medical International, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Smith & Nephew	0	6	0	0	2.00
Jin Medical International	0	0	0	0	0.00

Smith & Nephew presently has a consensus target price of $28.00, suggesting a potential downside of 2.06%. Given Smith & Nephew’s stronger consensus rating and higher possible upside, analysts plainly believe Smith & Nephew is more favorable than Jin Medical International.

Summary

Smith & Nephew beats Jin Medical International on 6 of the 8 factors compared between the two stocks.

About Smith & Nephew

Smith & Nephew plc engages in the development, manufacture, marketing, and sale of medical devices. It operates through the following segments: Orthopaedics, Sports Medicine and ENT, and Advanced Wound Management. The Orthopaedics and Sports Medicine and ENT segment consists of the following businesses: knee implants, hip implants, other reconstruction, trauma, sports medicine joint repair, arthroscopic enabling technologies, and ENT. The Advanced Wound Management segment includes advanced wound care, advanced wound bioactives, and advanced wound devices businesses. The company was founded in 1856 and is headquartered in Watford, the United Kingdom.

About Jin Medical International

Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited.